Shares of EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 27.74 ($0.34) and traded as low as GBX 27.10 ($0.33). EKF Diagnostics shares last traded at GBX 28.40 ($0.35), with a volume of 169,312 shares trading hands.
EKF Diagnostics Stock Performance
The stock has a 50 day moving average of GBX 26.11 and a 200 day moving average of GBX 27.73. The company has a market capitalization of £118.42 million, a price-to-earnings ratio of 2,610.00 and a beta of 0.57. The company has a quick ratio of 1.77, a current ratio of 4.59 and a debt-to-equity ratio of 1.78.
EKF Diagnostics Company Profile
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
Further Reading
- Five stocks we like better than EKF Diagnostics
- Where Do I Find 52-Week Highs and Lows?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- The Basics of Support and Resistance
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- How to Invest in Small Cap Stocks
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
